Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP Global Chief Med Officer
-
Stock Symbol
-
BSX on NYSE
There are no Buy or Sell transactions made by Ian T. Meredith since 9/18/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
28.1K |
$1.68M |
$60.00 |
Mar 28, 2022 |
Direct |
|
|
| Performance Share Units |
6.54K |
$378K |
$57.81 |
Feb 22, 2022 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
12.9K |
$225K |
$17.37 |
Feb 16, 2022 |
Direct |
Common Stock |
|
| Restricted Stock Units |
3.75K |
$203K |
$54.06 |
Feb 17, 2022 |
Direct |
Common Stock |
|
| Deferred Stock Units |
0 |
|
$54.06 |
Feb 28, 2022 |
Direct |
Common Stock |
|
Transactions reported by Ian T. Meredith for Boston Scientific Corp
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.